Magnesium supplementation for migraine prophylaxis

source extracted confidence: high 2026-04-09
#humans #migraine-disorders #dietary-supplements #magnesium #randomized-controlled-trials-as-topic

Magnesium supplementation for migraine prophylaxis

Rodriguez et al., 2025 | Cochrane Database Syst Rev | Other

Citation

Rodriguez Juan Pablo, Quarteroni Estefania, ... Garegnani Luis I. Magnesium supplementation for migraine prophylaxis. Cochrane Database Syst Rev. 2025-Nov-11;11(11):CD016307. doi:10.1002/14651858.CD016307

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of magnesium supplementation for preventing episodic or chronic migraine in children and adults compared to usual pharmacological treatment or placebo. Secondary objective To evaluate the benefits and harms of magnesium supplementation in different groups, specifically in terms of equity-related characteristics such as economic status, age, or sex.

Key Findings

Secondary objective To evaluate the benefits and harms of magnesium supplementation in different groups, specifically in terms of equity-related characteristics such as economic status, age, or sex.

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition See abstract

MeSH Terms

  • Humans
  • Migraine Disorders
  • Dietary Supplements
  • Magnesium
  • Randomized Controlled Trials as Topic
  • Child
  • Adult
  • Magnesium Sulfate

Evidence Classification

  • Level: Other
  • Publication Types: Journal Article
  • Vertical: cochrane-supplements

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09